NCT02942134

Brief Summary

Acute dyspnea after use of non-invasive ventilation (NIV) is a common phenomenon in patients with COPD and emphysema. This trial aims to document incidence and severity of augmented dyspnea in patients with long term NIV therapy. These findings may help in understanding the pathomechanisms that lead to post-NIV dyspnea and thus give way to potential therapy schemes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 21, 2016

Completed
11 days until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

October 21, 2016

Status Verified

October 1, 2016

Enrollment Period

11 months

First QC Date

October 20, 2016

Last Update Submit

October 20, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence and severity of acute dyspnea after use of non-invasive Ventilation in COPD and emphysema

    May 2018

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic hypercapnic failure due to COPD III to IV GOLD and emphysema on long term noninvasive ventilation

You may qualify if:

  • Males and females with stabile COPD, last exacerbation over one month,
  • GOLD III to IV
  • Regular use of noninvasive ventilation, more than four hours per day for more than one year
  • Signed declaration of consent
  • Sufficient language capabilities, german

You may not qualify if:

  • Acute exacerbation in the past four weeks
  • Acute pulmonary embolus
  • Haemoptysis
  • Severe neurological disease
  • Severe cardiological disease
  • Haemodynamic instability
  • New hypoxia or worsening of hypercapnia more than twenty percent of usual rate
  • Acute pneumothorax
  • Other instable Situation, for example intraabdominal bleedings
  • Drug or alcohol dependency
  • Regular intake of morphium
  • Adiposity BMI over 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Felix FJ Herth, Prof.

    Medical Director Thoraxklinik Heidelberg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. Felix JF Herth

Study Record Dates

First Submitted

October 20, 2016

First Posted

October 21, 2016

Study Start

November 1, 2016

Primary Completion

October 1, 2017

Study Completion

May 1, 2018

Last Updated

October 21, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share